For research use only. Not for therapeutic Use.
AChE-IN-26（Cat No.:I042826）is a promising acetylcholinesterase (AChE) inhibitor designed for the treatment of neurodegenerative diseases, particularly Alzheimer’s disease. By inhibiting AChE, it helps prevent the breakdown of acetylcholine, a neurotransmitter essential for memory and cognitive function. This results in enhanced cholinergic activity, which may improve symptoms such as memory loss and cognitive decline. AChE-IN-26 is being studied for its potential to slow disease progression and offer better therapeutic outcomes for patients with Alzheimer’s. Ongoing clinical trials focus on evaluating its effectiveness and safety profile in treating cognitive disorders.
| CAS Number | 2977170-10-6 |
| Synonyms | N-(1-benzylpyridin-1-ium-4-yl)-3,4-dimethoxybenzamide;bromide |
| Molecular Formula | C21H21BrN2O3 |
| Purity | ≥95% |
| IUPAC Name | N-(1-benzylpyridin-1-ium-4-yl)-3,4-dimethoxybenzamide;bromide |
| InChI | InChI=1S/C21H20N2O3.BrH/c1-25-19-9-8-17(14-20(19)26-2)21(24)22-18-10-12-23(13-11-18)15-16-6-4-3-5-7-16;/h3-14H,15H2,1-2H3;1H |
| InChIKey | VGTPSQFSPGENRA-UHFFFAOYSA-N |
| SMILES | COC1=C(C=C(C=C1)C(=O)NC2=CC=[N+](C=C2)CC3=CC=CC=C3)OC.[Br-] |
